相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
100+
- 英文名:
N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP / cpADP ), sodium salt
- CAS号:
681175-79-1
- 保质期:
咨询
- 供应商:
上海维亦特生物
- 保存条件:
依据标签
- 规格:
1mg
| 货号 | 英文名 | 别名 | CAS |
| WT-DM-B20020 | N6- Cyclopentyladenosine- 5'- O- monophosphate ( 6-cPe-5'-AMP ), sodium salt | 6-cPe-5'-AMP | [117778-38-8] |
| WT-DM-B20029 | N6- Methyladenosine- 5'- O- monophosphate ( 6-Me-5'-AMP ), sodium salt | 6-Me-5'-AMP | [81921-35-9] |
| WT-DM-B20077 | N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ), sodium salt | 6-Fu-ADP | [2378403-28-0] |
| WT-DM-B20085 | N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ), sodium salt | 6-Phe-ADP | [105701-92-6] |
| WT-DM-B20091 | N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP / cpADP ), sodium salt | 6-cPe-ADP / cpADP | [681175-79-1] |
| WT-DM-B20095 | N6- Cyclohexyladenosine- 5'- O- diphosphate ( 6-cHe-ADP ), sodium salt | 6-cHe-ADP | [2378403-29-1] |
| WT-DM-B20127 | N6- Cyclohexyladenosine- 5'- O- triphosphate ( 6-cHe-ATP ), sodium salt | 6-cHe-ATP | [206978-73-6] |
| WT-DM-B20129 | N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ), sodium salt | 6-Phe-ATP | [105740-47-4] |
| WT-DM-B20134 | N⁶- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP / Kinetin triphosphate / Kinetin riboside-5'-O-triphosphate / KTP ), sodium salt | 6-Fu-ATP | [1450894-16-2] |
| WT-DM-B20144 | N6- Cyclopentyladenosine- 5'- O- triphosphate ( 6-cPe-ATP ), sodium salt | 6-cPe-ATP | [189822-11-5] |
| WT-DM-B20146 | N⁶- Methyladenosine- 5'- O- triphosphate ( 6-Me-ATP ), sodium salt | 6-Me-ATP | [3130-39-0] |
| WT-DM-B20009 | N6- Benzoyladenosine- 5'- O- monophosphate ( 6-Bnz-5'-AMP ), sodium salt | 6-Bnz-5'-AMP | [40871-55-4] |
| WT-DM-B20052 | N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(1-MeBu)-ADP ), sodium salt | 6-(1-MeBu)-ADP | [N/A] |
| WT-DM-B20058 | N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(2-MeBu)-ADP ), sodium salt | 6-(2-MeBu)-ADP | [681175-77-9] |
| WT-DM-B20063 | N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3-MeBn)-ADP ), sodium salt | 6-(3-MeBn)-ADP | [681175-78-0] |
| WT-DM-B20081 | N6- (3- [Biotinyl]aminopropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-4-ADP / 6-[Biotin]-APr-ADP ), sodium salt | 6-Biotin-4-ADP | [N/A] |
| WT-DM-B20086 | N6- Benzyladenosine- 5'- O- diphosphate ( 6-Bn-ADP ), sodium salt | 6-Bn-ADP | [40811-89-0] |
| WT-DM-B20101 | N6- (2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ), sodium salt | 6-PhEt-ADP | [681175-76-8] |
| WT-DM-B20109 | N6- (4- Aminobutyl)adenosine- 5'- O- triphosphate ( 6-AB-ATP ), sodium salt | 6-AB-ATP | [280577-98-2] |
| WT-DM-B20115 | N6- Benzyladenosine- 5'- O- triphosphate ( 6-Bn-ATP ), sodium salt | 6-Bn-ATP | [40922-97-2] |
| WT-DM-B20120 | N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(2-MeBu)-ATP ), sodium salt | 6-(2-MeBu)-ATP | [252889-14-8] |
| WT-DM-B20142 | N6- (2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ), sodium salt | 6-PhEt-ATP | [181705-62-4] |
| WT-DM-B20162 | N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(1-MeBu)-ATP ), sodium salt | 6-(1-MeBu)-ATP | [252889-13-7] |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验| 货号 | 英文名 | 别名 | CAS |
| WT-DM-B20020 | N6- Cyclopentyladenosine- 5'- O- monophosphate ( 6-cPe-5'-AMP ), sodium salt | 6-cPe-5'-AMP | [117778-38-8] |
| WT-DM-B20029 | N6- Methyladenosine- 5'- O- monophosphate ( 6-Me-5'-AMP ), sodium salt | 6-Me-5'-AMP | [81921-35-9] |
| WT-DM-B20077 | N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ), sodium salt | 6-Fu-ADP | [2378403-28-0] |
| WT-DM-B20085 | N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ), sodium salt | 6-Phe-ADP | [105701-92-6] |
| WT-DM-B20091 | N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP / cpADP ), sodium salt | 6-cPe-ADP / cpADP | [681175-79-1] |
| WT-DM-B20095 | N6- Cyclohexyladenosine- 5'- O- diphosphate ( 6-cHe-ADP ), sodium salt | 6-cHe-ADP | [2378403-29-1] |
| WT-DM-B20127 | N6- Cyclohexyladenosine- 5'- O- triphosphate ( 6-cHe-ATP ), sodium salt | 6-cHe-ATP | [206978-73-6] |
| WT-DM-B20129 | N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ), sodium salt | 6-Phe-ATP | [105740-47-4] |
| WT-DM-B20134 | N⁶- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP / Kinetin triphosphate / Kinetin riboside-5'-O-triphosphate / KTP ), sodium salt | 6-Fu-ATP | [1450894-16-2] |
| WT-DM-B20144 | N6- Cyclopentyladenosine- 5'- O- triphosphate ( 6-cPe-ATP ), sodium salt | 6-cPe-ATP | [189822-11-5] |
| WT-DM-B20146 | N⁶- Methyladenosine- 5'- O- triphosphate ( 6-Me-ATP ), sodium salt | 6-Me-ATP | [3130-39-0] |
| WT-DM-B20009 | N6- Benzoyladenosine- 5'- O- monophosphate ( 6-Bnz-5'-AMP ), sodium salt | 6-Bnz-5'-AMP | [40871-55-4] |
| WT-DM-B20052 | N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(1-MeBu)-ADP ), sodium salt | 6-(1-MeBu)-ADP | [N/A] |
| WT-DM-B20058 | N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(2-MeBu)-ADP ), sodium salt | 6-(2-MeBu)-ADP | [681175-77-9] |
| WT-DM-B20063 | N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3-MeBn)-ADP ), sodium salt | 6-(3-MeBn)-ADP | [681175-78-0] |
| WT-DM-B20081 | N6- (3- [Biotinyl]aminopropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-4-ADP / 6-[Biotin]-APr-ADP ), sodium salt | 6-Biotin-4-ADP | [N/A] |
| WT-DM-B20086 | N6- Benzyladenosine- 5'- O- diphosphate ( 6-Bn-ADP ), sodium salt | 6-Bn-ADP | [40811-89-0] |
| WT-DM-B20101 | N6- (2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ), sodium salt | 6-PhEt-ADP | [681175-76-8] |
| WT-DM-B20109 | N6- (4- Aminobutyl)adenosine- 5'- O- triphosphate ( 6-AB-ATP ), sodium salt | 6-AB-ATP | [280577-98-2] |
| WT-DM-B20115 | N6- Benzyladenosine- 5'- O- triphosphate ( 6-Bn-ATP ), sodium salt | 6-Bn-ATP | [40922-97-2] |
| WT-DM-B20120 | N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(2-MeBu)-ATP ), sodium salt | 6-(2-MeBu)-ATP | [252889-14-8] |
| WT-DM-B20142 | N6- (2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ), sodium salt | 6-PhEt-ATP | [181705-62-4] |
| WT-DM-B20162 | N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(1-MeBu)-ATP ), sodium salt | 6-(1-MeBu)-ATP | [252889-13-7] |
CPE),算法应该是一样的,从表上也可看出,50% 的抑制浓度应该在10-0.6 到10-0.9 之间。距离比例=(68.57-50)/(68.57-42.42)=0.710150% 的抑制浓度的对数=0.6+0.7101X0.3=0.813050% 的抑制浓度=1:6.501请教:重组腺病毒载体(非复制型的)在感染的目的细胞中(体内和体外)可以持续表达多长时间?如果用 MOI=100 的病毒感染细胞,与 100TCID50 感染细胞是一样的么?不好意思,新手上路,还请上面的各位大虾多多
Construction and Characterization of Adenovirus Vectors
as described above or in suspension. Grow the cells in suspension in 1X maintenance medium in suspension flasks, agitated at 70 rpm. When they reach a density of 5 x 105 cells/mL, dilute 1:2 or 1:3 with 1X maintenance medium. CsCl (cesium chloride
的Caspase-3及对底物多聚(ADP-核糖)聚合酶[poly(ADP-ribose)polymerase,PARP]等的裂解。方法: 收集细胞→PBS洗涤→抽提细胞裂解液→蛋白定量→SDS-PAGE电泳→硝酸纤维素膜或PVDF膜转移→5%脱脂奶粉封闭,室温1.5~2h或4°C过夜→Caspase-3多抗或单抗室温反应1~2h或4°C过夜→TBS-T(含0.05% Tween 20的TBS)洗3次,5~10min/次→HRP-标记的羊抗鼠IgG或AP标记的羊抗鼠IgG室温反应1~2h→ TBS-T洗3次
技术资料暂无技术资料 索取技术资料








